NURO News Alert Neurometrix Inc (NURO) 1.78 12/25/2014 04:22

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neurometrix Inc (NURO) 1.78 $NURO

NeuroMetrix Selected to Showcase Quell(TM) Wearable Pain Relief Technology at 2015 CES Unveiled
Business Wire - Tue Dec 16, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015.
NURO: 1.78 (unch)

Natus Medical (BABY) Hits 52-Week High on Bullish Trends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 1:05PM CST
Shares of Natus Medical Inc. (BABY) scaled a 52-week high of $35.93 on Dec 9 and closed a trifle lower at $35.70, representing a healthy year-to-date return of approximately 58.7%.
JNJ: 104.59 (+0.31), BABY: 36.45 (+1.14), ALOT: 15.21 (+0.29), NURO: 1.78 (unch)

NeuroMetrix Expands Intellectual Property for Wearable Pain Relief Technology
Business Wire - Wed Dec 10, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) reported today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering unique aspects of the Company's wearable pain relief technology. The patent addresses an important element in the Company proprietary OptiTherapy(TM) technology that automatically controls nerve stimulation to optimize pain relief. In particular, the patent covers the automated calibration procedure that determines the appropriate stimulation level for each device user. The Company expects the patent to issue in mid-2015 and to extend patent protection into 2032. The technology is incorporated in the currently marketed prescription SENSUS(R) pain management device and in Quell(TM) which will be unveiled at the International Consumer Electronics Show (CES) in Las Vegas in January 2015.
NURO: 1.78 (unch)

NeuroMetrix to Participate in the Benchmark Micro Cap Discovery Conference
Business Wire - Mon Dec 08, 11:59AM CST
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be participating in the one-on-one Benchmark Micro Cap Discovery Conference which will be held at the Palmer House Hilton, Chicago, IL on Thursday, December 11, 2014 from 8:00am to 2:30pm. Dr. Gozani intends to provide a business update and discuss development progress on Quell(TM), the Company's over the counter wearable pain relief device which will be unveiled at the International Consumer Electronics Show (CES) in Las Vegas in January 2015. To schedule a one-on-one meeting with Dr. Gozani please e-mail vcuratola@benchmarkcompany.com or contact your Benchmark representative.
NURO: 1.78 (unch)

NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 International Consumer Electronics Show
Business Wire - Wed Nov 19, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell(TM), the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015.
NURO: 1.78 (unch)

NeuroMetrix ups revenues 8% in Q3
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:44PM CDT

NURO: 1.78 (unch)

NeuroMetrix's (NURO) CEO Shai Gozani on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 10:31AM CDT

NURO: 1.78 (unch)

NeuroMetrix Q3 EPS of -$0.19
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 6:07AM CDT

NURO: 1.78 (unch)

NeuroMetrix Reports Third Quarter 2014 Financial Results and Business Highlights
Business Wire - Tue Oct 28, 6:00AM CDT
--Progress with over-the-counter wearable device to treat chronic pain
NURO: 1.78 (unch)

NeuroMetrix reports October 28
Seeking Alpha - at Seeking Alpha - Tue Oct 21, 6:43AM CDT

NURO: 1.78 (unch)

NeuroMetrix, Inc. Announces Date for 2014 Third Quarter Financial Results Conference Call
Business Wire - Tue Oct 21, 6:00AM CDT
NeuroMetrix, Inc. (the "Company" (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to issue its 2014 third quarter financial results before the opening of the market on October 28, 2014. The Company will host a conference call at 8:00 a.m., Eastern Time on October 28, 2014 to discuss its financial results as well as business developments affecting the Company.
NURO: 1.78 (unch)

3 Breakout Stocks Under $10 for Your Watch List
at The Street - Wed Oct 08, 7:25AM CDT
Keep an eye on these under-$10 stocks for breakout trades.
RDNT: 9.41 (-0.08), NURO: 1.78 (unch), FSGI: 2.29 (+0.02)

NeuroMetrix Reports Publication of Study Demonstrating that DPNCheck is Effective at Detecting Diabetic Peripheral Neuropathy at all Stages of Severity
Business Wire - Thu Sep 25, 6:00AM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today reported publication of results from a DPNCheck(R) study conducted at the Diabetes Research Unit of the Ipswich Hospital NHS Trust in the United Kingdom. The study by Sharma and colleagues titled "Assessment of Diabetic Neuropathy Using a Point-of-Care Nerve Conduction Device Shows Significant Associations With the LDIFLARE Method and Clinical Neuropathy Scoring" was published in the Journal of Diabetes Science and Technology and is available at:
NURO: 1.78 (unch)

NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic Complications
Business Wire - Tue Sep 23, 12:49PM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of The Japan Society of Diabetic Complications to be held in Tokyo on October 3 and 4, 2014. The Japan Society of Diabetic Complications is a part of The Japan Diabetes Society which was established in 1958 to promote diabetes-related academic research and treatment programs. The organization has over 16,000 members and works in collaboration with other international organizations including the International Diabetes Federation (IDF), the American Diabetes Association (ADA), and the European Association for the Study of Diabetes (EASD). The Annual Meeting of the Japan Society of Diabetic Complications is one of the major events of the Japan Diabetes Society.
NURO: 1.78 (unch)

NeuroMetrix Names Senior Executive to Lead Consumer Healthcare Initiative Frank McGillin - SVP and GM, Consumer
Business Wire - Wed Sep 03, 6:00AM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the Company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement.
NURO: 1.78 (unch)

NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
Business Wire - Tue Sep 02, 2:51PM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel, New York, NY on September 8-10, 2014. Dr. Gozani intends to provide an update on the Company's business activities including the SENSUS(R) Pain Management System for chronic pain and sleep, and the Company's emerging consumer healthcare initiative.
NURO: 1.78 (unch)

Bacterin Announces the Appointment of New Board Member
GlobeNewswire - Wed Aug 13, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo (Nasdaq:MASI). The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Bacterin would like to thank Mr. Godfrey for his years of service and dedication to the Company.
MASI: 26.60 (+0.04), BONE: 2.59 (-0.02), NURO: 1.78 (unch)

NeuroMetrix Reports Second Quarter 2014 Financial Results and Business Highlights
Business Wire - Thu Jul 24, 6:00AM CDT
--FDA regulatory clearance for over-the-counter wearable technology to treat chronic pain
NURO: 1.78 (unch)

NeuroMetrix Marks 10th Year Anniversary of Listing on NASDAQ
Business Wire - Tue Jul 22, 6:00AM CDT
NeuroMetrix, Inc. (NASDAQ: NURO) reported today that it had reached the 10th anniversary of its initial listing on NASDAQ.
NURO: 1.78 (unch)

NeuroMetrix, Inc. Announces Date for 2014 Second Quarter Financial Results Conference Call
Business Wire - Thu Jul 17, 2:32PM CDT
NeuroMetrix, Inc. (the "Company" (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to issue its 2014 second quarter financial results before the opening of the market on July 24, 2014. The Company will host a conference call at 8:00 a.m., Eastern Daylight Time on July 24, 2014 to discuss its financial results as well as business developments affecting the Company.
NURO: 1.78 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 64

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 68

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 115

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 66

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 103

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Senior Living: The BrainFit Gym Experience

Updated Category News Views 330

Introducing the BrainFit Gym at The Bristal The Bristal Assisted Living is taking a bold step towards promoting cognitive wellness among seniors with their newly launched BrainFit Gym. Located at The Bristal at York Avenue, this unique facility stands out as a pioneering initiative aimed at enhancing the mental capacities of its residents. With this innovative approach,...

Continue Reading
Bullish (BLSH) Stock Surges After Thrilling IPO Success

Updated Category News Views 262

Bullish Stock Makes a Remarkable Entrance on the Market Recently, the cryptocurrency exchange Bullish (BLSH) took the public market by storm with its much-anticipated initial public offering (IPO). Its shares soared following trading debut, generating excitement among investors and analysts alike. Key Highlights of the IPO Supported by the renowned billionaire venture...

Continue Reading
Medius Honored as Top Microsoft Partner for Innovative Finance

Updated Category News Views 118

Medius Named 2024 Microsoft ISV Partner of the Year Medius, a leader in Accounts Payable (AP) Automation and Spend Management solutions, has reached an impressive milestone by being honored as the 2024 Microsoft ISV Partner of the Year. This esteemed award showcases Medius' dedication to innovation and excellence in improving finance operations through technology. The...

Continue Reading
Day One Biopharmaceuticals Set to Reveal Q1 2025 Financials

Updated Category News Views 309

Day One Biopharmaceuticals Plans Q1 2025 Financial Report Day One Biopharmaceuticals (NASDAQ: DAWN) is gearing up for a significant event. The biopharmaceutical company, known for its dedication to developing targeted therapies for serious illnesses, has announced a live conference call and webcast set for early May 2025. This event offers a chance for stakeholders to...

Continue Reading
Navigating the Future of Nonprofit Fundraising in 2025

Updated Category News Views 441

Nonprofit Fundraising Trends for 2025 As we approach the year 2025, nonprofits are setting their sights on innovative tactics that will not only enhance their fundraising efforts but also embrace the changing dynamics of donor engagement. Recent insights reveal that the landscape of nonprofit fundraising is evolving, making adaptability a core component of success in the...

Continue Reading